Results for
""Olanzapine""[mesh_terms]

Olanzapine effectiveness on weight gain in anorexia nervosa patients: systematic review and meta-analysis.

Bushra F Alqurashi, Anas R Alserihi, Ahmed Albariqi, Abdulmajeed Ayesh Alenazi, Yosra Alhindi, Rawan Lafi Alghamdi, Bander Abdullah Alotaibi, Sobhia Nasser Abanmi, Fares Abdulrahman Alhejaili, Fatimah Hassan Nahhas

BMC psychiatry 2026;26(1):

Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis.

Rong Li, Yiqi Zhang, Wenqiang Zhu, Chen Ding, Wenjie Dai, Xin Su, Wen Dai, Jingmei Xiao, Zhenhua Xing, Xiansheng Huang

Scientific reports 2020;10(1):17028

New discoveries for an old drug: a review of recent olanzapine research.

Amir M Meftah, Elizabeth Deckler, Leslie Citrome, Joshua T Kantrowitz

Postgraduate medicine 2020;132(1):80-90

Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis.

Farid Jabbar, Kurt Buhagiar

Clinical drug investigation 2019;39(3):253-273

Meta-analysis of ghrelin alterations in schizophrenia: Effects of olanzapine.

Ryan L Goetz, Brian J Miller

Schizophrenia research 2020;206():21-26

Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.

Rosa Rojo, Ricardo Gómez-Huelgas, Miquel Bernardo, Fernando Rico-Villademoros, Clemente García-Rizo

Advances in therapy 2021;38(5):2491-2512

Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug.

Jie-Er Ying, Xiao-Ling Zhang

Current oncology (Toronto, Ont.) 2022;29(11):8235-8243

Olanzapine poisoning in patients treated at the National Poison Control Centre in Belgrade, Serbia in 2017 and 2018: a brief review of serum concentrations and clinical symptoms.

Slavica Vučinić, Jasmina Jović Stošić, Gordana Vuković Ercegović, Vesna Kilibarda, Marko Antunović, Nataša Perković Vukčević, Snežana Đorđević

Arhiv za higijenu rada i toksikologiju 2022;73(2):126-130

Olanzapine-associated diabetes mellitus.

P Murali Doraiswamy, Elizabeth A Koller

Pharmacotherapy 2003;22(7):841-52

Reviewing the Potential Therapeutic Approaches Targeting the Modulation of Gastrointestinal Microflora in Schizophrenia.

Romeo Dobrin, Bogdan Doroftei, Irina Dobrin, Luminita-Diana Hritcu, Alin Ciobica, Ilinca-Bianca Nita, Ovidiu-Dumitru Ilie

International journal of molecular sciences 2022;23(24):

Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature.

Barbara Fulton, Karen Connolly, Mritunjay Kumar Varma

Journal of intensive care medicine 2007;22(1):52-5

Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials.

Weiyan Wang, Renrong Wu, Jingping Zhao, John M Davis, Fangkun Liu, Xiaoyi Wang, Xingjie Peng, Bing Lang, Yujun Long, Jingmei Xiao, Chenchen Liu, Ye Yang, Fengyu Zhang, Dongyu Kang, Jing Huang

Schizophrenia bulletin 2022;48(4):850-859

Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.

Dora Koller, Susana Almenara, Gina Mejía, Miriam Saiz-Rodríguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Marcos Navares-Gómez, Elena Santos-Molina, Elena Pintos-Sánchez, Francisco Abad-Santos

Advances in therapy 2021;38(2):1035-1054

The Impact of Adjunctive Aripiprazole on Olanzapine-Induced Metabolic Adverse Effects in Patients With Schizophrenia: A Systematic Review.

Soban Sadiq, Stephen Simmons

Neuropsychopharmacology reports 2025;45(3):e70046